我如何使用azacitidine和venetoclax治疗AML患者
Andrew H Wei1,2, Sun Loo1,2,3, Naval Daver4
1Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
Blood
|September 24, 2024
概括
威尼托克拉克斯与阿扎西提丁结合,为老年患者的急性髓性白血病 (AML) 提供了一种新的治疗方法. 谨慎管理至关重要,以减轻与这种有效的AML治疗相关的骨髓抑制和感染风险.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 威尼托克拉克斯 (VEN) 于2020年10月获得全面批准,用于治疗急性髓性白血病 (AML) 的老年患者,不适合进行密集化疗.
- 这标志着在几十年来,AML治疗这一群体的进展有限之后,取得了重大进展.
- VEN被批准与低甲基化剂或低剂量cytarabine结合使用,提供更好的反应和存活率.
研究的目的:
- 突出 AML 中基于 venetoclax 的疗法临床管理中的挑战和困境.
- 在临床实践中提供一个结构化的框架来安全地使用阿扎西丁-VEN (AZA-VEN).
- 为了解决与AZA-VEN相关的骨髓抑制和传染性并发症风险.
主要方法:
- 对AML的临床数据和已确定的治疗原则的审查.
- 讨论瘤溶解综合征和诱导期间感染并发症的管理策略.
- 概述了优化放疗后护理的方法,包括骨髓恢复和VEN暴露持续时间.
主要成果:
- 阿扎西提丁-VEN (AZA-VEN) 在改善老年AML患者的反应和生存方面表现出有效性.
- 与单独使用azacitidine相比,AZA-VEN疗法与显著的骨髓抑制和感染风险增加有关.
- 有效的管理需要积极的策略来预防和管理毒性.
结论:
- 阿扎西提丁和维尼托克拉克斯的组合代表了对老年,不适合的AML患者的新标准护理.
- 尽量减少骨髓抑制和传染性并发症对于安全有效的AZA-VEN治疗至关重要.
- 结构化的管理框架对于优化结果和患者安全至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:10Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K